Review Article
Prognostic Value of Long Noncoding RNAs in Patients with Gastrointestinal Cancer: A Systematic Review and Meta-Analysis
Table 1
Characteristics of studies and lncRNA expression related to OS in GIC patients.
| References | lncRNAs () | Year | Nations | Number () | OS | Cut-off value | Detection methods | Sample types | Follow-up | HR | 95% CI |
| Sun et al. [13] | RNAGAS5↓ | 2014 | China | 89 GC | 2.43 | 1.29–4.59 | Median | RT-PCR | Tissue | <40 | Li et al. [29] | SNHG20↑ | 2016 | China | 107 CRC | 2.97 | 1.51–5.82 | YI | RT-PCR | Tissue | <40 | Kong et al. [15]! | PVT1↑ | 2015 | China | 80 GC | 2.09 | 1.07–4.10 | Median | RT-PCR | Tissue | <40 | Qi et al. [31] | AGAP2-AS1↑ | 2017 | China | 50 GC | 2.67# | 1.45–4.93 | Median | RT-PCR | Tissue | 6–36# | Chen et al. [32] | XIST↑ | 2016 | China | 106 GC | 3.11 | 1.67–3.78 | Median | RT-PCR | Tissue | <120 | Ye et al. [33] | lnc-GNAT1-1↓ | 2016 | China | 68 CRC | 2.16 | 1.01–4.63 | Median | RT-PCR | Tissue | <20 | Saito et al. [21] | ATB↑ | 2015 | Japan | 183 GC | 3.50 | 1.73–7.44 | Median | RT-PCR | Tissue | 0.192–134.4 | Yuan et al. [35]! | PVT1↑ | 2016 | China | 111 GC | 2.28 | 1.05–4.93 | Median | RT-PCR | Tissue | 20–48 | Ye et al. [36] | CLMAT3↑ | 2015 | China | 90 CRC | 2.05 | 1.10–3.82 | Dichotomize | RT-PCR | Tissue | <45 | Zheng et al. [37]! | UCA1↑ | 2015 | China | 112 GC | 2.35 | 1.22–4.52 | Dichotomize | RT-PCR | Tissue | <92 | Chen et al. [38] | NEAT1↑ | 2015 | China | 96 EC | 1.92 | 1.40–6.49 | YI | RT-PCR | Tissue | <80 | Wang et al. [39]! | CCAT2↑ | 2016 | China | 108 GC | 2.11 | 1.44–3.20 | Median | RT-PCR | Tissue | <70 | Zhao et al. [22] | HOTAIR↑ | 2015 | China | 168 GC | 1.47 | 1.04–2.06 | Median | RT-PCR | Tissue | <70 | Zhang et al. [40] | Sox2ot↑ | 2016 | China | 132 GC | 2.05 | 1.28–3.30 | Median | RT-PCR | Tissue | <96 | Chen et al. [41] | HIF1A-AS2↑ | 2015 | China | 83 GC | 1.72 | 1.00–2.96 | Median | RT-PCR | Tissue | <60 | Li et al. [10] | HOTAIR↑ | 2013 | China | 100 EC | 1.91 | 1.06–4.00 | 125-fold | RT-PCR | Tissue | <60 | Yue et al. [42]! | FER1L4↓ | 2015 | China | 70 CC | 3.99 | 1.67–9.01 | Median | RT-PCR | Tissue | <80 | He et al. [43] | CCAT1↑ | 2014 | China | 48 CC | 2.09# | 1.42–3.06 | Median | RT-PCR | Tissue | 24–37# | Yin et al. [44] | MEG3↓ | 2015 | China | 62 CRC | 0.13 | 0.02–0.99 | Mean | RT-PCR | Tissue | <60 | Nie et al. [45] | MIR31HG↓ | 2016 | China | 48 CC | 2.35# | 1.15–4.79 | Median | RT-PCR | Tissue | 3–36# | Park et al. [46] | BM742401↓ | 2013 | Korea | 113 GC | 1.03 | 0.57–1.88 | Median | RT-PCR | Tissue | <80 | Liu et al. [23] | CRNDE-h↑ | 2016 | China | 148 CRC | 2.39 | 1.30–4.39 | Median | RT-PCR | Serum | 1–65 | Li et al. [47] | PANDAR↑ | 2017 | China | 102 CRC | 3.08 | 0.84–7.89 | Median | RT-PCR | Tissue | <60 | Chen et al. [48]! | H19↑ | 2016 | China | 128 GC | 1.96 | 0.97–3.97 | Median | RT-PCR | Tissue | 20–48 | Zou et al. [49]! | Sox2ot↑ | 2016 | China | 155 GC | 3.24 | 1.24–6.43 | Median | RT-PCR | Tissue | <70 | Jiang et al. [50] | TUG1↑ | 2016 | China | 218 EC | 1.40 | 1.01–1.95 | NR | RT-PCR | Tissue | 12–72 | Svoboda et al. [51] | HOTAIR↑ | 2014 | Czech | 84 CRC | 5.9 | 1.34–26.1 | Median | RT-PCR | Blood | 12–54 | Wang et al. [52]! | OTUB1-isoform 2↑ | 2016 | China | 156 GC | 1.54 | 1.04–2.27 | Median | RT-PCR | Tissue | <80 | Guo et al. [53] | FTX↑ | 2015 | China | 187 CRC | 2.37 | 1.42–2.74 | Median | RT-PCR | Tissue | <60 | Pan et al. [54] | FOXCUT↑ | 2014 | China | 82 EC | 2.13# | 1.38–3.29 | Mean | RT-PCR | Tissue | 1–72 | Zhou et al. [55] | LET↓ | 2014 | China | 93 GC | 2.28 | 1.30–5.18 | Mean | RT-PCR | Tissue | <60 | Hu et al. [56] | linc-UBC1↑ | 2015 | China | 85 GC | 3.56# | 1.71–7.39 | Median | RT-PCR | Tissue | <100 | Wang et al. [57] | CCAT2↑ | 2015 | China | 86 GC | 2.41 | 1.19–5.42 | Mean | RT-PCR | Tissue | <60 | Ren et al. [58] | HOTTIP↑ | 2015 | China | 156 CRC | 2.15 | 1.31–3.42 | Median | RT-PCR | Tissue | 33–65 | Liu et al. [59]! | DANCR↑ | 2015 | China | 104 CRC | 2.13 | 1.16–7.06 | Median | RT-PCR | Tissue | <60 | Wang et al. [60]! | ZEB1-AS1↑ | 2015 | China | 87 EC | 2.37 | 1.28–6.12 | Median | RT-PCR | Tissue | <61 | Li et al. [61] | BANCR↑ | 2015 | China | 184 GC | 1.51 | 1.03–2.23 | Median | RT-PCR | Tissue | 5–93 | Ma [62]! | PANDAR↑ | 2016 | China | 100 GC | 3.68 | 1.13–12.06 | NR | RT-PCR | Tissue | 2–36 | Huang et al. [63] | MALAT1↑ | 2016 | China | 132 EC | 6.64 | 2.95–14.95 | NR | RT-PCR | Tissue | <60 | Ni et al. [64] | UCA1↑ | 2015 | China | 54 CRC | 3.11# | 0.59–16.39 | Median | RT-PCR | Tissue | 9–51# | Wu et al. [25] | uc002yug.2↑ | 2014 | China | 684 EC | 2.61 | 1.50–3.78 | NR | RT-PCR | Tissue | <140 | Sun et al. [16] | HOXA11-AS↑ | 2016 | China | 85 GC | 2.85# | 1.65–4.91 | Median | ISH | Tissue | 9–36 | Peng et al. [65]! | NEAT1↑ | 2016 | China | 56 CRC | 1.70# | 1.04–2.80 | NR | RT-PCR | Tissue | <60 | Jiao et al. [66] | UCA1↑ | 2016 | China | 66 EC | 2.24# | 1.17–4.29 | Median | RT-PCR | Tissue | 5–30# | Liu and Shangguan [67] | CARLo-5↑ | 2017 | China | 240 GC | 2.41 | 1.13–5.94 | 0.041 | RT-PCR | Tissue | <60 | Ma et al. [11] | CCAL↑ | 2016 | China | 252 CRC | 2.25 | 1.35–3.74 | Median | RT-PCR | Tissue | <100 | Yang et al. [18] | GHET1↑ | 2014 | China | 42 GC | 1.90# | 0.53–6.85 | Median | RT-PCR | Tissue | 7–40# | Wu et al. [68] | HOTAIR↑ | 2014 | China | 120 CC | 3.92 | 1.23–12.50 | 5-fold | RT-PCR | Tissue | 10–72 | Zhou et al. [69]! | ROR↑ | 2016 | China | 60 CC | 7.22 | 2.43–17.43 | Median | RT-PCR | Tissue | <80 | Yang et al. [70]! | Loc554202↓ | 2016 | China | 178 CRC | 2.45 | 1.34–7.74 | Median | RT-PCR | Tissue | <70 | Lü et al. [71] | BC032469↑ | 2016 | China | 58 GC | 2.78# | 0.95–8.09 | Mean | RT-PCR | Tissue | <23 | Su et al. [72] | BLACAT1↑ | 2017 | China | 48 CRC | 1.50 | 1.32–1.70 | Mean | RT-PCR | Tissue | <60 | Hu et al. [12] | GAPLINC↑ | 2014 | China | 90 GC | 1.54 | 1.22–1.94 | Median | ISH | Tissue | <80 | Fu et al. [73] | NEAT1↑ | 2016 | China | 140 GC | 1.61 | 1.03–2.53 | Median | RT-PCR | Tissue | <96 | Yao et al. [26] | RP11-766N7.4↓ | 2017 | China | 50 EC | 2.14# | 1.10–4.15 | Median | RT-PCR | Tissue | 32–60# | Xie et al. [74] | SPRY4-IT1↑ | 2014 | China | 92 EC | 2.05 | 1.04–4.03 | Median | RT-PCR | Tissue | 3–60 | Peng [75]! | SPRY4-IT1↑ | 2015 | China | 175 GC | 0.82 | 0.31–1.57 | Median | RT-PCR | Tissue | <60 | Nie et al. [76]! | ZFAS1↑ | 2016 | China | 54 GC | 2.08# | 1.11–3.93 | Median | RT-PCR | Tissue | 3–36# | Ohtsuka et al. [77] | H19↑ | 2016 | USA | 117 CC | 1.28 | 1.08–1.50 | 0.64 | RT-PCR | Tissue | <90 | Li et al. [20] | MALAT1↑ | 2017 | China | 68 CRC | 2.17# | 1.32–3.55 | Median | RT-PCR | Tissue | 1–51# | Zhou et al. [78] | AFAP1-AS1↑ | 2016 | China | 162 EC | 1.89 | 1.22–2.92 | Median | RT-PCR | Tissue | 6–72 | Sun et al. [80]! | RP11-119F7.4↓ | 2015 | China | 96 GC | 1.20# | 0.84–1.71 | Median | RT-PCR | Tissue | <100 | Zhang et al. [81]! | ANRIL↑ | 2014 | China | 120 GC | 1.74 | 1.04–2.93 | 3-fold | RT-PCR | Tissue | <60 | Li et al. [82]! | NEAT1↑ | 2015 | China | 239 CRC | 1.70 | 1.18–2.45 | 2-fold | RT-PCR | Tissue | <60 | Chen et al. [83] | LINC00152↑ | 2016 | China | 97 GC | 1.66 | 1.01-2.73 | Median | RT-PCR | Tissue | <60 | Chen et al. [19] | FEZF1-AS1↑ | 2016 | China | 153 CRC | 2.40 | 1.07–5.41 | NR | ISH | Tissue | <100 | Han et al. [84]! | H19↑ | 2016 | China | 83 CRC | 1.43 | 1.24–1.79 | 3-fold | RT-PCR | Tissue | <50 | Yang et al. [85] | GAPLINC↑ | 2016 | China | 180 CRC | 2.21 | 1.38–3.57 | NR | ISH | Tissue | <100 | Jin et al. [86] | HULC↑ | 2016 | China | 54 GC | 1.92# | 1.00–3.67 | 2-fold | RT-PCR | Serum | 11–32# | Cao et al. [87]! | BC200↑ | 2016 | China | 70 EC | 2.24 | 1.12–4.49 | Median | RT-PCR | Tissue | <50 | Cao et al. [88] | SPRY4-IT1↑ | 2016 | China | 84 CRC | 3.21 | 1.55–6.67 | 2.87-fold | RT-PCR | Tissue | 3–36 | Gao et al. [89] | linc-UBC1↑ | 2017 | China | 96 CRC | 2.43 | 1.09–5.42 | Median | RT-PCR | Tissue | <60 | Wang et al. [90]! | AFAP1-AS1↑ | 2016 | China | 52 CRC | 2.36 | 1.11–5.01 | Median | RT-PCR | Tissue | <50 | Ge et al. [91] | PCAT-1↑ | 2013 | China | 108 CRC | 3.12 | 1.36–7.19 | NR | RT-PCR | Tissue | <100 | Deng et al. [92] | 91H↑ | 2014 | China | 72 CRC | 3.66 | 1.66–8.10 | 2.86-fold | RT-PCR | Tissue | 2–36 | Sun et al. [93]! | AK098081↑ | 2016 | China | 84 CRC | 1.90 | 1.39–2.58 | Mean | RT-PCR | Tissue | 1–118# | Xu et al. [94]! | FENDRR↓ | 2014 | China | 158 GC | 1.76 | 1.04–3.12 | Median | RT-PCR | Tissue | 20–48 | Bian et al. [96] | UCA1↑ | 2016 | China | 90 CRC | 2.40 | 1.04-5.50 | Median | RT-PCR | Tissue | <100 | Zuo et al. [97] | UCA1↑ | 2017 | China | 37 GC | 2.92 | 1.07–7.96 | Median | RT-PCR | Tissue | <40 | Lu et al. [98] | PANDAR↑ | 2017 | China | 124 CRC | 3.53 | 1.41–4.45 | Median | RT-PCR | Tissue | <60 | Lv et al. [99] | MEG3↓ | 2016 | China | 96 EC | 2.12 | 1.05–4.27 | NR | RT-PCR | Tissue | <120 | Xu et al. [100] | TUSC7↓ | 2017 | China | 63 CRC | 2.92 | 1.03–8.33 | NR | RT-PCR | Tissue | <120 | Ma et al. [101] | DUXAP8↑ | 2016 | China | 72 GC | 2.37# | 1.39–4.05 | Median | RT-PCR | Tissue | 5–36# | Fei et al. [103]! | LINC00982↓ | 2016 | China | 106 GC | 2.87 | 1.34–6.17 | Median | RT-PCR | Tissue | 20–48 | Chen et al. [104]! | SNHG15↑ | 2016 | China | 106 GC | 2.93 | 1.30–6.58 | Median | RT-PCR | Tissue | 20–48 | Tan et al. [105] | SPRY4-IT1↑ | 2017 | China | 106 CRC | 2.34 | 1.14–4.83 | Mean | RT-PCR | Tissue | <70 | Wang and Xing [106] | ZFAS1↑ | 2016 | China | 159 CRC | 1.88∗ | 1.01–3.53 | Median | RT-PCR | Tissue | <101 | Yao et al. [107] | MALAT-1↑ | 2016 | China | 137 EC | 1.27# | 0.90–1.80 | 0.5-fold | RT-PCR | Tissue | 3–36# | Liu et al. [108]! | BANCR↑ | 2016 | China | 142 EC | 0.95∗ | 0.21–0.95 | Median | RT-PCR | Tissue | 1–60# | Chen et al. [109] | HOTAIR↑ | 2013 | China | 78 EC | 2.40 | 1.35–4.28 | Mean | RT-PCR | Tissue | 2–60 | Hu et al. [102]a | Linc00152↑ | 2016 | China | 205 EC | 1.89 | 1.22–2.58 | Upper 95% CI in control group | RT-PCR | Plasma | <60 | POU3F3↑ | 1.82 | 1.17–2.51 | CFLAR↑ | 1.68 | 1.08–2.32 | Yu et al. [110] | u50535↑ | 2018 | China | 98CRC | 4.01 | 1.06–15.14 | NR | RT-PCR | Tissue | <60 | Jiang et al. [111] | CRNDE↑ | 2017 | China | 251CRC | 1.69 | 1.05–2.74 | NR | ISH | Tissue | 1–117 | Cui et al. [112] | HEIH↑ | 2018 | China | 84CRC | 1.46 | 1.02–2.08 | Median | RT-PCR | Tissue | <60 | Wu et al. [113]! | GHRLOS↓ | 2017 | China | 366CRC | 1.96 | 1.34–2.86 | 1/2-fold | RT-PCR | Tissue | 5–85 | Li et al. [115] | ZEB1-AS1↑ | 2017 | China | 24GC | 2.36 | 1.41–3.96 | Median | RT-PCR | Tissue | 72 | Huang et al. [116] | LINC00673↑ | 2017 | China | 73GC | 2.38 | 1.12–5.06 | 2-fold | RT-PCR | Tissue | <20 | Li et al. [117] | PVT1↑ | 2017 | China | 104ESCC | 2.75 | 1.35–5.59 | Median | RT-PCR | Tissue | <80 | Shi et al. [118] | ZFAS1↑ | 2017 | China | 246ESCC | 1.59 | 1.07–2.36 | Median | RT-PCR | Tissue | 114 | Wu et al. [119] | XIST↑ | 2017 | China | 127ESCC | 2.4 | 1.44–4.01 | Median | RT-PCR | Tissue | <80 | Ba et al. [120] | LINC00673↑ | 2017 | China | 79GC | 2.56 | 1.01–4.54 | Median | RT-PCR | Tissue | <50 | Zhu et al. [121] | SNHG1↑ | 2017 | China | 108CRC | 3.17 | 1.55–6.21 | Median | RT-PCR | Tissue | <50 | Yang et al. [122] | LINC01133↓ | 2018 | China | 149ESCC | 2.18 | 1.23–3.85 | Median | RT-PCR | Tissue | <60 |
|
|
aOne study involved lncRNA Linc00152, lncRNA POU3F3, and lncRNA CFLAR. indicates adjusted HR; # indicates calculated HR of OS and follow-up time; ! indicates studies included OS and DFS; ↑ or ↓ indicates upregulated or downregulated with poor prognosis. OS: overall survival; DFS: disease-free survival; HR: hazard ratio; CI: confidence interval; EC: esophageal cancer; GC: gastric cancer; CRC: colorectal cancer; GIC: gastrointestinal cancer; NR: no report; YI: Youden index; RT-PCR: reverse transcription PCR; ISH: in situ hybridization. |